How can Lycra® sleeves improve upper limb functioning in hemiplegic cerebral palsy?

How can soft dynamic pressure orthoses (Lycra®) influence upper limb functioning in children with spastic hemiplegic cerebral palsy?

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN67208261

Enrollment

Registered

2019-06-25

Start date

2019-07-15

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic hemiplegic cerebral palsy Nervous System Diseases Spastic hemiplegic cerebral palsy

Interventions

Treatment provided: Lycra made-to-measure sleeve Sleeve Wear Protocol: The recommended wear protocol is 7 days/week for a maximum duration of 6 hours/day. This wear routine will be fol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Cerebral Palsy (Spastic Hemiplegic), as confirmed by a referring professional 2. Age between 5-18 3. Able to sit independently on a chair without armrests 4. Able to understand and follow instructions

Exclusion criteria

Exclusion criteria: 1. Botulinum Toxin Injection within the past six months 2. Previous orthopaedic surgery for upper limb 3. Use of Soft Dynamic Pressure Orthosis or similar compression garment treatment in the past two years 4. No significant decrease in PROM due to musculoskeletal contracture or deformities at the elbow and/or wrist.

Design outcomes

Primary

Measure	Time frame
1. Shriner's Hospital Upper Extremity Evaluation (SHUEE) will measure changes in activity-related use of the affected arm at first and third visits 2. Cerebral Palsy Quality of Life Questionnaire (CPQOL) will measure the satisfaction level of a participant in utilising the affected arm in daily living activities at first and third visits 3. Active/Passive Range of movement (at elbow, forearm, and wrist) measured using biometric electrogoniometer at second and third visits 4. Spasticity electrophysiological measures (at elbow and wrist) measured using neurophysiological measures using biometrics wireless kit (goniometer, myometer & electromyography) at second and third visits 5. Stiffness measure (at elbow and wrist) measured using modified Ashworth scale at second and third visits 6. Tactile Threshold (monofilament test) measured using Semmen Weinstein monofilament (20-piece set) at second and third visits 7. Stereognosis test measured using 10-item kit at second and third visits 8. Proprioception test (at elbow and wrist) measured using biometric electrogoniometer at second and third visits	—

Measure

Time frame

1. Shriner's Hospital Upper Extremity Evaluation (SHUEE) will measure changes in activity-related use of the affected arm at first and third visits 2. Cerebral Palsy Quality of Life Questionnaire (CPQOL) will measure the satisfaction level of a participant in utilising the affected arm in daily living activities at first and third visits 3. Active/Passive Range of movement (at elbow, forearm, and wrist) measured using biometric electrogoniometer at second and third visits 4. Spasticity electrophysiological measures (at elbow and wrist) measured using neurophysiological measures using biometrics wireless kit (goniometer, myometer & electromyography) at second and third visits 5. Stiffness measure (at elbow and wrist) measured using modified Ashworth scale at second and third visits 6. Tactile Threshold (monofilament test) measured using Semmen Weinstein monofilament (20-piece set) at second and third visits 7. Stereognosis test measured using 10-item kit at second and third visits 8. Proprioception test (at elbow and wrist) measured using biometric electrogoniometer at second and third visits

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026